On this page
Phenylketonuria
PKU is caused by changes in the PAH gene, leading to a build-up of phenylalanine in the blood. If left untreated, this can cause significant health problems, primarily affecting brain development. Early diagnosis through newborn screening and lifelong dietary management are crucial for individuals with PKU.
Available at Jeen Health
Clinical tests that include this
Overview
Phenylketonuria (PKU) is a rare inherited metabolic condition. It means the body is unable to process an amino acid called phenylalanine, which is found in most protein-containing foods. Without the enzyme needed to break it down, phenylalanine builds up in the blood and can become toxic. This build-up, if not managed, can lead to serious health problems, particularly affecting brain development [PMID:31804648].
PKU is typically detected shortly after birth through the NHS Newborn Blood Spot Screening Programme in the UK. This early identification is vital, as starting treatment quickly can prevent severe complications. The condition affects approximately 1 in 10,000 to 15,000 newborns in the UK, though exact prevalence can vary [PMID:33618362].
Lifelong management, primarily through a carefully controlled diet, allows individuals with PKU to lead full and healthy lives. Advances in understanding and treatment mean that most people diagnosed with PKU today, especially in countries with comprehensive newborn screening, have a very good prognosis.
Symptoms & clinical features
Untreated PKU can lead to a range of symptoms, primarily affecting neurological development. In the early stages, symptoms may not be obvious, which is why newborn screening is so important. If the condition remains undiagnosed and untreated, high levels of phenylalanine can become toxic to the brain.
Potential symptoms in untreated individuals may include developmental delay, learning difficulties, and behavioural issues. Other features could involve seizures, tremors, and problems with movement [PMID:31804648]. Some individuals might also have lighter skin, hair, and eye colour compared to other family members, as phenylalanine is involved in the production of melanin, the pigment that gives colour to skin and hair. A characteristic musty odour in the breath, skin, or urine can also be present due to the build-up of phenylalanine by-products. However, with early diagnosis and strict dietary management, these severe symptoms can typically be prevented.
Video: Genetics 101
Affected organs
The primary organ affected by untreated Phenylketonuria is the brain. High levels of phenylalanine are neurotoxic, meaning they can damage brain cells and impair brain development [PMID:31804648]. This can lead to the neurological and developmental issues seen in individuals with untreated PKU.
While the brain is most significantly impacted, other systems can also show effects. For example, the impaired production of melanin, which is downstream from phenylalanine metabolism, can result in lighter skin and hair pigmentation. The liver is the main site where phenylalanine is normally processed, so genetic changes affecting the enzyme in the liver are the root cause, but the liver itself is not typically damaged by PKU.
Risks & severity
The severity of Phenylketonuria symptoms is directly related to the level of phenylalanine in the blood, which in turn depends on the extent of the enzyme's deficiency. There is a spectrum of PKU, ranging from classic (severe) PKU to milder forms like variant PKU or non-PKU hyperphenylalaninaemia (nHPA). Individuals with classic PKU have very little or no enzyme activity, leading to a significant build-up of phenylalanine if not treated.
Without treatment, classic PKU can lead to severe and irreversible intellectual disability, neurological problems, and behavioural issues. However, with early diagnosis through newborn screening and consistent dietary management from infancy, individuals with PKU can typically avoid these severe complications and achieve normal development [PMID:33618362]. Lifelong management is crucial, as even moderate increases in phenylalanine levels later in life can affect cognitive function and mental health. The age of onset for symptoms, if untreated, would typically be in infancy and early childhood, progressing over time.
Genetic causes
Phenylketonuria is caused by genetic changes in the PAH gene. This gene provides instructions for making an enzyme called phenylalanine hydroxylase. This enzyme is essential for converting phenylalanine, an amino acid obtained from the diet, into another amino acid called tyrosine.
When there are pathogenic variants (changes) in the PAH gene, the phenylalanine hydroxylase enzyme may be absent, reduced, or non-functional. This means that phenylalanine cannot be properly processed and instead accumulates in the blood and other body tissues. High levels of phenylalanine are toxic to the developing brain. The specific type of genetic change in the PAH gene often influences the residual activity of the enzyme, which in turn affects the severity of PKU [PMID:31804648].
- PAH phenylalanine hydroxylaseThe PAH gene provides instructions for producing phenylalanine hydroxylase, an enzyme crucial for metabolising the amino acid phenylalanine.
Inheritance pattern
Phenylketonuria is inherited in an autosomal recessive pattern. This means that a person must inherit two altered copies of the PAH gene - one from each parent - to develop the condition. If a person inherits only one altered copy of the PAH gene and one normal copy, they are considered a 'carrier' [PMID:33618362].
Carriers typically do not have PKU symptoms because their one working copy of the gene produces enough phenylalanine hydroxylase enzyme. When two carriers have a child together, there is a 25% chance with each pregnancy that the child will inherit two altered gene copies and develop PKU. There is also a 50% chance the child will be a carrier, and a 25% chance the child will inherit two normal gene copies and not be affected or a carrier.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
In the UK, Phenylketonuria is primarily diagnosed through the NHS Newborn Blood Spot Screening Programme. This involves taking a small blood sample from a baby's heel a few days after birth to test for several rare but serious conditions, including PKU. Elevated phenylalanine levels detected through this screening prompt further confirmatory tests, such as additional blood phenylalanine measurements and genetic testing.
Genetic testing for changes in the PAH gene can confirm the diagnosis of PKU and identify the specific genetic variants responsible. This information can sometimes help predict the severity of the condition and guide treatment options. In cases where PKU is suspected later in life due to symptoms, a clinical genetics team or metabolic specialist would typically refer for diagnostic testing. For specific genetic testing related to PKU, relevant NHS Genomic Medicine Service R-codes would be used to guide testing strategies.
Management & lifestyle
Management of Phenylketonuria in the UK is primarily focused on lifelong dietary control to maintain phenylalanine levels within a safe range. This involves a low-protein diet, limiting foods rich in phenylalanine such as meat, fish, eggs, dairy, nuts, and certain grains. Special medical foods and phenylalanine-free protein substitutes are essential to ensure adequate nutrition and support growth and development [PMID:33618362].
Dietary management is typically overseen by a specialist metabolic dietitian in close collaboration with a paediatrician or metabolic consultant. Regular blood tests are required to monitor phenylalanine levels, especially during infancy and childhood, and throughout adulthood. Some individuals with specific genetic variants may benefit from a medication called sapropterin (Kuvan), which can help improve the activity of the phenylalanine hydroxylase enzyme. Ongoing support from a specialist metabolic team, including genetic counsellors and psychologists, is an integral part of the NHS care pathway for PKU, helping individuals and families manage the condition effectively and maintain good quality of life.
UK care pathway
In the UK, individuals with Phenylketonuria are supported through a well-established NHS care pathway. This journey typically begins with the NHS Newborn Blood Spot Screening Programme, which identifies affected babies shortly after birth. Following a positive screen, families are referred to a specialist metabolic centre.
These centres provide multidisciplinary care, including specialist metabolic paediatricians, dietitians, and genetic counsellors. Genetic testing, guided by NHS Genomic Medicine Service R-codes, confirms the diagnosis and identifies the specific genetic changes. Genetic counsellors offer crucial support, explaining the inheritance pattern, implications for family members, and reproductive options. This coordinated approach ensures early intervention and lifelong management, empowering individuals with PKU to thrive.
Frequently asked questions
What happens if PKU is not treated?
If Phenylketonuria is not treated, high levels of phenylalanine can build up in the brain. This can lead to severe and irreversible learning difficulties, developmental delay, behavioural problems, and other neurological issues like seizures.
Can someone with PKU eat any protein?
Individuals with PKU must follow a very strict low-protein diet. They need to carefully limit foods naturally high in protein, such as meat, fish, eggs, dairy, and nuts. However, they are provided with special medical formulas that contain amino acids but are phenylalanine-free, ensuring they still get essential nutrients.
How is PKU diagnosed in the UK?
In the UK, PKU is primarily diagnosed through the NHS Newborn Blood Spot Screening Programme, also known as the 'heel prick test'. This test is offered to all babies a few days after birth to detect several rare but serious conditions, including PKU, enabling early treatment.
Is PKU inherited from parents?
Yes, PKU is an inherited condition. It follows an autosomal recessive pattern, meaning a child must inherit two altered copies of the PAH gene - one from each parent - to have the condition. Parents who each carry one altered copy are typically unaffected but can pass it on.
Will my child need a special diet forever?
Yes, dietary management for PKU is typically lifelong. While some aspects of the diet may become more flexible in adulthood, consistent control of phenylalanine levels through a special diet and medical foods is generally required to prevent cognitive and other health issues.
References
- Talebi S, Eshraghi P. Nutrition in phenylketonuria. Clinical nutrition ESPEN. 2024. PMID: 39427751
- Phenylketonuria (PKU). 1994. PMID: 35952089
- Koch R, Wenz E. Phenylketonuria. Annual review of nutrition. 1987. PMID: 3300729
- Tajima T. Newborn Screening in Japan-2021. International journal of neonatal screening. 2022. PMID: 35076455
- Remmington T, Smith S. Tyrosine supplementation for phenylketonuria. The Cochrane database of systematic reviews. 2021. PMID: 33427303
- Purnell H. Phenylketonuria and maternal phenylketonuria. Breastfeeding review : professional publication of the Nursing Mothers' Association of Australia. 2001. PMID: 11550601
- Hsia DY. Phenylketonuria 1967. Developmental medicine and child neurology. 1967. PMID: 4863975
- Hanley WB. Adult phenylketonuria. The American journal of medicine. 2004. PMID: 15465508